Drug firms would prioritize EU over smaller UK market post Brexit warns ABPI
Drug companies will prioritize the EU over the UK in the event of Brexit according to the ABPI, which says members recognize the benefits of centralised licensing.
Archives for May 8, 2016
Catalent's oral biz hit by Beinheim suspension and low modified release demand
The manufacturing suspension at a French softgel plant and low demand for modified release tech stunted Catalent’s Q3 2016 results, the firm says.
Europe delays Merck & Co.'s HCV drug on back of CMO quality issues
Inadequate record keeping at Merck & Co.’s contract manufacturer has delayed the European launch of its hepatitis C drug Zepatier (elbasvir and grazoprevir).
Pfizer, Wave Life Sciences partner on drug development
Wave Life Sciences is partnering with Pfizer to develop genetically targeted therapies to treat metabolic diseases.
Impurity isolation and sample purification
Paid for and content provided by RSSL
During a manufacturing process unexpected and unknown impurities may arise in a sample. It is important that such impurities are isolated and identified.